1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- AbbVie Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Ophthalmology Therapeutics Market 2021-2025
The publisher has been monitoring the ophthalmology therapeutics market and it is poised to grow by $12.34 bn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven increase in prevalence of eye diseases, , and strong uptake of anti-VEGF inhibitors. In addition, increase in prevalence of eye diseases is anticipated to boost the growth of the market as well.
The ophthalmology therapeutics market analysis includes product segment and geographical landscapes.
The ophthalmology therapeutics market is segmented as below:
By Product
By Geographical Landscapes
This study identifies the approval of novel therapeutics and strong drug pipeline as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years.
Thereport on ophthalmology therapeutics market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
The publisher has been monitoring the ophthalmology therapeutics market and it is poised to grow by $12.34 bn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven increase in prevalence of eye diseases, , and strong uptake of anti-VEGF inhibitors. In addition, increase in prevalence of eye diseases is anticipated to boost the growth of the market as well.
The ophthalmology therapeutics market analysis includes product segment and geographical landscapes.
The ophthalmology therapeutics market is segmented as below:
By Product
- Retinal disorder therapeutics
- Glaucoma therapeutics
- Dry eye disease therapeutics
- Eye infections and inflammation therapeutics
- Other therapeutics
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the approval of novel therapeutics and strong drug pipeline as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years.
Thereport on ophthalmology therapeutics market covers the following areas:
- Ophthalmology therapeutics market sizing
- Ophthalmology therapeutics market forecast
- Ophthalmology therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AbbVie Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AbbVie Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
The publisher recognizes the following companies as the key players in the global ophthalmology therapeutics market: AbbVie Inc., Aerie Pharmaceuticals Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd..
Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is approval of novel therapeutics and strong drug pipeline.'
According to the report, one of the major drivers for this market is the increase in prevalence of eye diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is approval of novel therapeutics and strong drug pipeline.'
According to the report, one of the major drivers for this market is the increase in prevalence of eye diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Aerie Pharmaceuticals Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown